1[1]Attisano,L,Wrana JL.Signal transduction by the TGF-beta superfamily[J].Science,2002,296(5573):1646-1647.
2[2]Di jke P,Miyazono K,Heldin Ch.Signaling inputs converg on nuclear effectors in TGF-β signaling[J].TIBS,2000,25(2):64-70.
3[3]Massague J,Wotton D.Transcriptionl control by the TGF-beta/Smad signaling system[J].Embo J,2000,19(8):1745-1754.[4]Piek E,Heldin CH,Ten Dijke P.Specificity,divercity and regulation in TGF-beta superfamily signaling[J].Faseb J,1999,13(5):2105-2124.
4[4]Sano Y,Harada J,Tashiro S,et al.ATF-2 is a common target of Smad and TAK1 pathway intransforming growthfactor-β singnaling[J].J boil Chem,1999,274(13):8949-8957.
5[5]Pasche B.Role of TGF-β in Cancer[J].J cell Physiol,2001,186(2):153-168.
6[6]Liu JH,Weis,Bumette PK,et al.Functional association of TGF-beta receptor Ⅱwith cyclin B[J].Oncogen,1999,18(1):169-175.
7[7]Giehlk,Seidel B,Gierschik P,et al.TGF-beta repress proliferation of pancreatic carcinoma cells which correlates with Smad4-independent inhibition of ERK activation[J].Oncogene,2000,19(39):4531-4541.
8[8]Prunier C,Ferrand N,Frottier B,et al.Mechanism for mutational inactivation of the tumor suppressor Smad2[J].Mol Cell Biol,2001,21(10):302-3313.
9[9]Xu J,Attisanp L.Mutations in the tumor suppressors Smad2 and Smad4 inactivate transforming growth factor beta signaling by targeting Smads to the ubquitin-proteasome pathway[J].Proc Natl Acad Sci USA,2000,97(9):4820-4825.
